showed that visfatin plays a critical role in osteoblast differentiation and stimulates osteogenesis by epigenetically regulating Runx2 expression, demonstrating that visfatin may be an important therapeutic target in senile osteoporosis (99). This evidence concerns the gene NAMPT and osteoporosis.